Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies
- PMID: 11117547
Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies
Abstract
Dysferlin has recently been identified as a novel gene involved in limb-girdle muscular dystrophy type 2B (LGMD2B) and its allelic disease, Miyoshi myopathy. The predicted structure of dysferlin suggests that it is a transmembrane protein possibly involved in membrane fusion. Thus, unlike previously identified structural proteins in muscular dystrophy, dysferlin is likely involved in a novel pathogenic mechanism for this disease. In this study, we have analyzed the expression of dysferlin in skeletal muscle of patients with disruptions in the dystrophin-glycoprotein complex and patients with a clinical diagnosis of LGMD2B or Miyoshi myopathy. We show expression of dysferlin at the sarcolemma in normal muscle and reduced sarcolemmal expression along with accumulation of intracellular staining in dystrophic muscle. Electron microscopy in Miyoshi myopathy biopsies suggests that the cytoplasmic staining could be a result of the abundance of intracellular vesicles. Our results indicate that dysferlin expression is perturbed in LGMD and that both mutations in the dysferlin gene and disruption of the dystrophin-glycoprotein complex can lead to the accumulation of dysferlin within the cytoplasm.
Similar articles
-
Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.Hum Mol Genet. 2004 Sep 15;13(18):1999-2010. doi: 10.1093/hmg/ddh212. Epub 2004 Jul 14. Hum Mol Genet. 2004. PMID: 15254015
-
Defective membrane repair in dysferlin-deficient muscular dystrophy.Nature. 2003 May 8;423(6936):168-72. doi: 10.1038/nature01573. Nature. 2003. PMID: 12736685
-
Variable reduction of caveolin-3 in patients with LGMD2B/MM.J Neurol. 2003 Dec;250(12):1431-8. doi: 10.1007/s00415-003-0234-x. J Neurol. 2003. PMID: 14673575
-
Dysferlin and the plasma membrane repair in muscular dystrophy.Trends Cell Biol. 2004 Apr;14(4):206-13. doi: 10.1016/j.tcb.2004.03.001. Trends Cell Biol. 2004. PMID: 15066638 Review.
-
Miyoshi myopathy patients with novel 5' splicing donor site mutations showed different dysferlin immunostaining at the sarcolemma.Acta Neuropathol. 2002 Dec;104(6):615-20. doi: 10.1007/s00401-002-0593-x. Epub 2002 Jul 19. Acta Neuropathol. 2002. PMID: 12410383 Review.
Cited by
-
Next-generation sequencing identified a novel DYSF variant in a patient with limb-girdle muscular dystrophy type 2B: A case report.Medicine (Baltimore). 2020 Oct 9;99(41):e22615. doi: 10.1097/MD.0000000000022615. Medicine (Baltimore). 2020. PMID: 33031319 Free PMC article.
-
Statin therapy and the expression of genes that regulate calcium homeostasis and membrane repair in skeletal muscle.Am J Pathol. 2010 Jul;177(1):291-9. doi: 10.2353/ajpath.2010.091140. Epub 2010 May 20. Am J Pathol. 2010. PMID: 20489141 Free PMC article.
-
Reduced plasma membrane expression of dysferlin mutants is attributed to accelerated endocytosis via a syntaxin-4-associated pathway.J Biol Chem. 2010 Sep 10;285(37):28529-39. doi: 10.1074/jbc.M110.111120. Epub 2010 Jul 1. J Biol Chem. 2010. PMID: 20595382 Free PMC article.
-
Dysferlin, annexin A1, and mitsugumin 53 are upregulated in muscular dystrophy and localize to longitudinal tubules of the T-system with stretch.J Neuropathol Exp Neurol. 2011 Apr;70(4):302-13. doi: 10.1097/NEN.0b013e31821350b0. J Neuropathol Exp Neurol. 2011. PMID: 21412170 Free PMC article.
-
Ferlins: regulators of vesicle fusion for auditory neurotransmission, receptor trafficking and membrane repair.Traffic. 2012 Feb;13(2):185-94. doi: 10.1111/j.1600-0854.2011.01267.x. Epub 2011 Sep 6. Traffic. 2012. PMID: 21838746 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical